“No DFU Goes Unstudied”: The Diabetic Foot Consortium #DFC Biomarker Platform Study from Brings Master-Protocol Design to Wound Healing #DFU #DiabeticFoot

Our colleagues at the NIDDK Diabetic Foot Consortium have published the methodologic scaffolding the field has needed: a platform study—master-protocol trial design borrowed from oncology and COVID-19 vaccines—applied for the first time to DFU biomarker validation. Their mantra: No DFU Goes Unstudied.

Measuring progress to healing: A challenge and an opportunity – The value of wound margin advancement

Great, provocative work by our colleagues Prof. Keith Harding and coworkers. Use of the radius, rather than surface area or percent wound area reduction may be a way forward Advance of wound margin, rather than PWAR or gross area reduction may be a more consistent surrogate method to evaluate healing rate Complete healing is problematic... Continue Reading →

Up ↑

Verified by MonsterInsights